A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo

References

• MartinGSSepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomesExpert Rev Anti Infect Ther201210670170622734959
   PubMed Web of Science ®Google Scholar
• LevyMMFinkMPMarshallJC2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conferenceCrit Care Med20033141250125612682500
   PubMed Web of Science ®Google Scholar
• HotchkissRSMonneretGPayenDImmunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachLancet Infect Dis201313326026823427891
   PubMed Web of Science ®Google Scholar
• CohenJThe immunopathogenesis of sepsisNature2002420691788589112490963
   PubMed Web of Science ®Google Scholar
• RemickDGNewcombDEBolgosGLCallDRComparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation find punctureShock200013211011610670840
   PubMed Web of Science ®Google Scholar
• DejagerLPinheiroIDejonckheereELibertCCecal ligation and puncture: the gold standard model for polymicrobial sepsis?Trends Microbiol201119419820821296575
   PubMed Web of Science ®Google Scholar
• WillenbergIRundKRongSShushakovaNGuelerFSchebbNHCharacterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsisInflamm Res20166513314226645911
   PubMed Web of Science ®Google Scholar
• RittirschDHoeselLMWardPAThe disconnect between animal models of sepsis and human sepsisJ Leuko Biol200781113714317020929
   PubMed Web of Science ®Google Scholar
• IwasakiAMedzhitovRRegulation of adaptive immunity by the innate immune systemScience2010327596329129520075244
   PubMed Web of Science ®Google Scholar
• SchulteWBernhagenJBucalaRCytokines in sepsis: potent immunoregulators and potential therapeutic targets – an updated viewMediators Inflamm2013201316597423853427
   PubMed Web of Science ®Google Scholar
• LichtensternCBrennerTBardenheuerHJWeigandMAPredictors of survival in sepsis: what is the best inflammatory marker to measure?Curr Opin Infect Dis201225332833622421751
   PubMed Web of Science ®Google Scholar
• LucasRVerinADBlackSMCatravasJDRegulators of endothelial and epithelial barrier integrity and function in acute lung injuryBiochem Pharmacol200977121763177219428331
   PubMed Web of Science ®Google Scholar
• KothariNBograJAbbasHTumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shockCytokine201361267668123317877
   PubMed Web of Science ®Google Scholar
• PooleDBertoliniGGarattiniSWithdrawal of ‘Xigris’ from the market: old and new lessonsJ Epidemiol Community Health201266757157222447955
   PubMed Web of Science ®Google Scholar
• TidswellMTillisWLarosaSPPhase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisCrit Care Med2010381728319661804
   PubMed Web of Science ®Google Scholar
• OpalSMLaterrePFFrancoisBEffect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialJAMA2013309111154116223512062
   PubMed Web of Science ®Google Scholar
• RiceTWWheelerAPBernardGRA randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsisCrit Care Med20103881685169420562702
   PubMed Web of Science ®Google Scholar
• GriceCATaysKLSavallBMIdentification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activityJ Med Chem200851144150416918588282
   PubMed Web of Science ®Google Scholar
• ChenGLiuZZhangYSynthesis and anti-inflammatory evaluation of novel benzimidazole and imidazopyridine derivativesACS Med Chem lett201341697424900565
   PubMed Web of Science ®Google Scholar
• BianYRenLWangLA novel imidazopyridine derivative, X22, prevents the retinal ischemia-reperfusion injury via inhibition of MAPKsExp Eye Res2015135263625907396
   PubMed Web of Science ®Google Scholar
• LiWWangLHuangWInhibition of ROS and inflammation by an imidazopyridine derivative X22 attenuate high fat diet-induced arterial injuriesVascular Pharmacol201572153162
   PubMed Web of Science ®Google Scholar
• WuJLiJCaiYEvaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agentsJ Med Chem201154238110812321988173
   PubMed Web of Science ®Google Scholar
• GuptaNSuXPopovBLeeJWSerikovVMatthayMAIntrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in miceJ Immunol200717931855186317641052
   PubMed Web of Science ®Google Scholar
• AdawiDKasraviFBMolinGJeppssonBEffect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the ratHepatology19972536426479049212
   PubMed Web of Science ®Google Scholar
• LiQYangSYangSXinFWangMAnti-inflammatory activity of phlomisoside F isolated from Phlomis younghusbandii MukerjeeInt Immunopharmacol201528172473026263166
   PubMed Web of Science ®Google Scholar
• GustotTMultiple organ failure in sepsis: prognosis and role of systemic inflammatory responseCurr Opin Crit Care201117215315921346564
   PubMed Web of Science ®Google Scholar
• BohannonJKLuanLHernandezARole of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injuryJ Leukoc Biol Epub2015114
   PubMed Web of Science ®Google Scholar
• ZhangQRaoofMChenYCirculating mitochondrial DAMPs cause inflammatory responses to injuryNature20104647285U104U115
   PubMed Web of Science ®Google Scholar
• PatilNKParajuliNMacMillan-CrowLAMayeuxPRInactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injuryAm J Physiol Renal Physiol20143067F734F74324500690
   PubMed Web of Science ®Google Scholar
• LeoneMTextorisJMichelFWiramusSMartinCEmerging drugs in sepsisExpert Opin Emerg Drugs2010151415220055688
   PubMed Web of Science ®Google Scholar
• SavarisRFde MoraesGSCristovamRABraunRDAre antibiotics necessary after 48 hours of improvement in infected/septic abortions? A randomized controlled trial followed by a cohort studyAm J Obstet Gynecol20112044301.e301e30521195382
   PubMed Web of Science ®Google Scholar
• KesselLTendalBJorgensenKJPost-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic reviewOphthalmology2014121101915192424935281
   PubMed Web of Science ®Google Scholar
• JaturapatpornDIsaacMGMcCleeryJTabetNAspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s diseaseCochrane Database Syst Rev20122CD00637822336816
   PubMed Web of Science ®Google Scholar
• EisenDPManifold beneficial effects of acetyl salicylic acid and non-steroidal anti-inflammatory drugs on sepsisIntensive Care Med20123881249125722531881
   PubMed Web of Science ®Google Scholar
• EisenDPReidDMcBrydeESAcetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsisCrit Care Med20124061761176722610182
   PubMed Web of Science ®Google Scholar
• BergKJAcute effects of acetylsalicylic acid in patients with chronic renal insufficiencyEur J Clin Pharmacol1977112111116837963
   PubMed Web of Science ®Google Scholar
• DaleJMyhreELoewDBleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacementAm Heart J19809967467526966467
   PubMed Web of Science ®Google Scholar
• WuJZhangYCaiYDiscovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agentsBioorg Med Chem201321113058306523611769
   PubMed Web of Science ®Google Scholar
• ZhangYJiangXPengKDiscovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcuminDrug Des Devel Ther2014821612171
   PubMed Web of Science ®Google Scholar
• DinarelloCAInterleukin-1 in the pathogenesis and treatment of inflammatory diseasesBlood2011117143720373221304099
   PubMed Web of Science ®Google Scholar
• BayraktarOTekinNAydinOAkyuzFMusmulABurukogluDEffects of S-allyl cysteine on lung and liver tissue in a rat model of lipopolysaccharide-induced sepsisNaunyn Schmiedebergs Arch Pharmacol2015388332733525480742
   PubMed Web of Science ®Google Scholar
• KimSJBaekKSParkHJ9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury by suppressing MAPK signaling in miceBr J Pharmacol2015 Epub ahead of print
   Web of Science ®Google Scholar
• MohantySGautamYMauryaAKIndenes and tetralenes analogues attenuates lipopolysaccharide-induced inflammation: an in-vitro and in-vivo studyChem Biol Interact2016245121926731479
   PubMed Web of Science ®Google Scholar
• MovahedMAZarghiADesign and synthesis of new imidazopyridine derivatives as selective COX-2 inhibitorsRes Pharm Sci201275S531
   Google Scholar
• LuY-CYehW-COhashiPSLPS/TLR4 signal transduction pathwayCytokine200842214515118304834
   PubMed Web of Science ®Google Scholar